PoliticalRepoPoliticalRepo

Bill · HR

H.R. 27 (119th)

HALT Fentanyl Act

Original

referredUnited States· United States Congress· EN

Introduced

3 January 2025

Last action

10 February 2025 · Introduced

Status

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Sponsors

Rep. Griffith, H. Morgan [R-VA-9], Rep. Latta, Robert E. [R-OH-5], Rep. Guthrie, Brett [R-KY-2], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Hudson, Richard [R-NC-9], Rep. Carter, Earl L. "Buddy" [R-GA-1], Gary Palmer, Rep. Dunn, Neal P. [R-FL-2], Rep. Crenshaw, Dan [R-TX-2], John Joyce, August Pfluger, Diana Harshbarger, Rep. Cammack, Kat [R-FL-3], Mariannette Miller-Meeks, Steve Womack, Rep. Buchanan, Vern [R-FL-16], Rep. Miller, Carol D. [R-WV-1], John Moolenaar, Rep. Bost, Mike [R-IL-12], Gabe Evans, Rep. Fitzgerald, Scott [R-WI-5], Nicholas Langworthy, Rep. Cline, Ben [R-VA-6], Rep. Meuser, Daniel [R-PA-9], Jefferson Van Drew, Rep. Feenstra, Randy [R-IA-4], Rep. Nunn, Zachary [R-IA-3], Rep. Ciscomani, Juan [R-AZ-6], Rep. Stauber, Pete [R-MN-8], Ann Wagner, Troy Balderson, Rep. Higgins, Clay [R-LA-3], Rep. Ellzey, Jake [R-TX-6], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Russell Fry, Rep. Houchin, Erin [R-IN-9], Harold Rogers, Jay Obernolte, Rep. Webster, Daniel [R-FL-11], Tim Burchett, Rep. Scott, Austin [R-GA-8], Rep. Walberg, Tim [R-MI-5], Rep. Fischbach, Michelle [R-MN-7], Rep. Wittman, Robert J. [R-VA-1], Gregory Murphy, Rep. Franklin, Scott [R-FL-18], Michael Baumgartner, Patrick Ryan, Bruce Westerman, Rep. Lawler, Michael [R-NY-17], Rep. Hill, J. French [R-AR-2], Rep. Newhouse, Dan [R-WA-4], Laura Gillen, Rep. Moore, Riley [R-WV-2], Mike Haridopolos, Rep. Messmer, Mark [R-IN-8], Julie Fedorchak, Rep. Goldman, Craig [R-TX-12], Rep. Barr, Andy [R-KY-6], Kevin Kiley, Rep. McGuire, John [R-VA-5], Nicholas Begich

Subjects

Crime and Law Enforcement

Source updated

10 August 2026

Crime and Law Enforcement

Official sourceDownload fileView documentsShare

Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the bill establishes a new, alternative registration process for certain schedule I research. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 3 January 2025

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 3 January 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 3 January 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 4 February 2025

    Reported

    Rules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.

    Source: Floor

  5. 5 February 2025

    Passed

    Rule H. Res. 93 passed House.

    Source: Floor

  6. 6 February 2025

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  7. 6 February 2025

    Vote

    On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)

    Source: Floor

  8. 6 February 2025

    Vote

    Passed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)

    Source: Floor

  9. 6 February 2025

    Floor

    Considered under the provisions of rule H. Res. 93. (consideration: CR H520-533)

    Source: Floor

  10. 6 February 2025

    Floor

    Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.

    Source: Floor

  11. 10 February 2025

    Introduced

    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    Source: IntroReferral

Votes

6 February 2025 · passed · On Passage · Passed · Official source

Yes 312 · No 108 · Abstain — · Absent/not voting 13

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

4 official files

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.